Notch signaling pathway activation in normal and hyperglycemic rats differs in the stem cells of visceral and subcutaneous adipose tissue

Stem Cells and Development

Volumn 23, Issue 24, 2014, Pages 3034-3048

  Ferrer Lorente, Raquel ^a   Bejar, Maria Teresa ^a   Badimon, Lina ^a,b  

^a CSIC   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; ESTER; N [N (3,5 DIFLUOROPHENACETYL ALANYL)] PHENYLGLYCINE TERT BUTYL ESTER; NOTCH RECEPTOR; PHENETHYL ISOTHIOCYANATE; PHENYLGLYCINE; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; DIPEPTIDE; HAIRY, HRT1 PROTEIN; HOMEODOMAIN PROTEIN; ISOTHIOCYANIC ACID DERIVATIVE; N-(N-(3,5-DIFLUOROPHENACETYL)ALANYL)PHENYLGLYCINE TERT-BUTYL ESTER; REPRESSOR PROTEIN;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMETABOLIC RISK; CELL DIFFERENTIATION; CONTROLLED STUDY; DIABETIC OBESITY; GENE EXPRESSION; HOMEOSTASIS; HYPERGLYCEMIA; INTRAABDOMINAL FAT; LIPID HOMEOSTASIS; LIPID STORAGE; MALE; NONHUMAN; PROTEIN MOTIF; RAT; STEM CELL; SUBCUTANEOUS FAT; UPREGULATION; ANIMAL; ANTIBODY SPECIFICITY; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; SIGNAL TRANSDUCTION; ZUCKER RAT;

RATTUS;

ADIPOGENESIS; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELLS, CULTURED; DIPEPTIDES; HOMEODOMAIN PROTEINS; HYPERGLYCEMIA; INTRA-ABDOMINAL FAT; ISOTHIOCYANATES; MALE; MESENCHYMAL STROMAL CELLS; ORGAN SPECIFICITY; RATS; RATS, ZUCKER; RECEPTORS, NOTCH; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT;

EID: 84916942507     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0070     Document Type: Article

References (57)

1. Eckel RH and RM Krauss. (1998). American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 97:2099-2100
2. Morelli M, M Gaggini, G Daniele, P Marraccini, R Sicari and A Gastaldelli. (2013). Ectopic fat: the true culprit linking obesity and cardiovascular disease? Thromb Haemost 110:651-660
3. Ibrahim MM. (2010). Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 11: 11-18
4. Klein S, L Fontana, VL Young, AR Coggan, C Kilo, BW Patterson and BS Mohammed. (2004). Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350:2549-2557
5. Fox CS, JM Massaro, U Hoffmann, KM Pou, P Maurovich-Horvat, CY Liu, RS Vasan, JM Murabito, JB Meigs, et al. (2007). Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116: 39-48
6. Snijder MB, M Visser, JM Dekker, BH Goodpaster, TB Harris, SB Kritchevsky, N De Rekeneire, AM Kanaya, AB Newman, FA Tylavsky and JC Seidell. (2005). Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipids levels, independently of high abdominal fat: the Health ABC Study. Diabetologia 48:301-308
7. Tran TT, Y Yamamoto, S Gesta and CR Kahn. (2008). Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 7:410-420
8. Tchernof A and JP Després. (2013). Pathophysiology of human visceral obesity: an update. Physiol Rev 93:359-404
9. Carey DG, AB Jenkins, LV Campbell, J Freund and DJ Chisholm. (1996). Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45:633-638
10. DeFronzo RA. (2010). Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernar Lecture 2009. Diabetologia 53:1270-1287
11. Gastaldelli A and G Basta. (2010). Ectopic fat and cardiovascular disease: what is the link? Nutr Metabol Cardiovasc Dis 20:481-490
12. Kabir M, KJ Catalano, S Ananthnarayan, SP Kim, GW Van Citters, MK Dea and RN Bergman. (2005). Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 288:454-461
13. Gray SL and A Vidal-Puig. (2007). Adipose tissue expandability in the maintenance of metabolic homeostasis. Nutr Rev 65:7-12
14. Tchkonia T, YD Tchoukalova, N Giorgadze, T Pirtshalava, I Karagiannides, RA Forse, A Koo, M Stevenson, D Chinnappan, et al. (2005). Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am J Physiol Endocrinol Metab 288:267-277
15. Ahima RS. (2006). Adipose tissue as an endocrine organ. Obesity 14:242-249
16. Gimble JM, F Guilak and BA Bunnell. (2010). Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther 1:19
17. Mizuno H, M Tobita and AC Uysal. (2012). Adiposederived stem cells as a novel tool for future regenerative medicine. Stem Cells 30:804-810
18. Rosen ED and OA MacDougald. (2006). Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7:885-896
19. Armani A, C Mammi, V Marzolla, M Calachini, A Antelmi, GMC Rosano, A Fabbri and M Caprio. (2010). Cellular models for understanding adipogenesis, adipose dysfunction, and obesity. J Cell Biochem 110:564-572
20. Lindsell CE, CJ Shawber, J Boulter and G Weinmaster. (1995). Jagged: a mammalian ligand that activates Notch1. Cell 80:909-917
21. Artavanis-Tsakonas S, MD Rand and RJ Lake. (1999). Notch Signaling: cell fate control and signal integration in development. Science 284:770-776
22. Chiba S. (2006). Concise review: Notch signaling in stem cell systems. Stem Cells 24:2437-2447
23. Liu J, C Sato, M Cerletti and A Wagers. (2010). Notch signaling in the regulation of stem cell self-renewal and differentiation. Curr Top Dev Biol 92:367-409
24. Mutyaba PL, NS Belkin, L Lopas, CF Gray, D Dopkin, KD Hankenson and J Ahn. (2014). Notch Signaling in mesenchymal stem cells (MSC) harvested from geriatric mice. J Orthop Trauma 8:20-23
25. Fortini ME and S Artavanis-Tsakonas. (1993). Notch: neurogenesis is only part of the picture. Cell 75:1245-1247
26. Jones P, G May, L Healy, J Brown, G Hoyne, S Delassus and T Enver. (1998). Stromal expression of Jagged1 promotes colony formation by fetal hematopoietic progenitor cells. Blood 92:1505-1511
27. Ross DA, PK Rao and T Kadesch. (2004). Dual roles for the notch target gene Hes-1 in the differentiation of 3T3-L1 preadipocytes. Mol Cell Biol 24:3505-3515
28. Ugarte F, M Ryser, S Thieme, FA Fierro, K Navratiel, M Bornhäuser and S Brenner. (2009). Notch signaling enhances osteogenic differentiation while inhibiting adipogenesis in primary human bone marrow stromal cells. Exp Hematol 37:867-875
29. Huang Y, X Yang, Y Wu, W Jing, X Cai, W Tang, L Liu, BE Grottkau and Y Lin. (2010). g-secretase inhibitor induces adipogenesis of adipose-derived stem cells by regulation of Notch and PPAR-g. Cell Prolif 43:147-156
30. Urs S, B Turner, Y Tang, B Rostama, D Small and L Liaw. (2012). Effect of soluble Jagged1-mediated inhibition of Notch signaling on proliferation and differentiation of an adipocyte progenitor cell model. Adipocyte 1:46-57
31. Osathanon T, K Subbalekha, P Sastravaha and P Pavasant. (2012). Notch signalling inhibits the adipogenic differentiation of single-cell-derived mesenchymal stem cell clones isolated from human adipose tissue. Cell Biol Int 36:1161-1170
32. Lei T, Y Bi, MJ Gao, SM Gao, LL Zhou, HL Zheng and XD Chen. (2013). HES1 inhibits adipogenesis of porcine mesenchymal stem cells via transcriptional repression of FAD24. Domest Anim Endocrinol 45:28-32
33. GarcésC, MJRuiz-Hidalgo, J Font deMoras, CPark, LMiele, J Goldstein, E Bonvini, A Porrás and J Laborda. (1997). Notch-1 controls the expression of fatty acid-Activated transcription factors and is required for adipogenesis. J Biol Chem 272: 29729-29734
34. Jung S, N Song, HS Hwang, JJ An, Y Cho, HY Kweon, S Kang, KG Lee, K Yoon, et al. (2011). Silk peptides inhibit adipocyte differentiation through modulation of the Notch pathway in C3H10T1/2 cells. Nutr Res 31:723-730
35. Ba K, X Yang, L Wu, X Wei, N Fu, Y Fu, X Cai, Y Yao, Y Ge and Y Lin. (2012). Jagged-1-mediated activation of notch signalling induces adipogenesis of adipose-derived stem cells. Cell Prolif 45:538-544
36. Lai PY, CB Tsai and MJ Tseng. (2013). Active form Notch4 promotes the proliferation and differentiation of 3T3-L1 preadipocytes. Biochem Biophys Res Commun 18:1132-1139
37. Ferrer-Lorente R, MT Bejar, M Tous, G Vilahur and L Badimon. (2014). Systems biology approach to identify alterations in the stem cell reservoir of subcutaneous adipose tissue in a rat model of diabetes: effects on differentiation potential and function. Diabetologia 57:246-256
38. Lapidus L, C Bengtsson, B Larsson, K Pennert, E Rybo and L Sjöström. (1984). Distribution of adipose tissue and risk of cardiovascular disease and death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Br Med J 289:1257-1261
39. Joe AWB, L Yi, Y Even, A Wayne Vogl and FMV Rossi. (2009). Depot-specific differences in adipogenic progenitor abundance and proliferative response to high-fat diet. Stem Cells 27:2563-2570
40. Cawthorn WP, EL Scheller and OA MacDougald. (2012). Adipose tissue stem cells meet preadipocyte commitment: going back to the future. J Lipid Res 53:227-246
41. Sengenas C, K Lolmede, A Zakaroff-Girard, R Busse and A Bouloumie. (2005). Preadipocytes in the human subcutaneous adipose tissue display distinct features from the adult mesenchymal and hematopoietic stem cells. J Cell Physiol 205:114-122
42. Hutley LJ, FS Newell, YH Kim, X Luo, CH Widberg, W Shurety, JB Prins and JP Whitehead. (2011). A putative role for endogenous FGF-2 in FGF-1 mediated differentiation of human preadipocytes. Mol Cell Endocrinol 339: 165-171
43. Bowers RR, JW Kim, TC Otto and MD Lane. (2006). Stable stem cell commitment to the adypocyte lineage by inhibition of DNA methylation: role of the BMP-4 gene. Proc Natl Acad Sci U S A 130:13022-13027
44. Bowers RR and MD Lane. (2008). Wnt signaling and adipocyte lineage commitment. Cell Cycle 7:1191-1196
45. Spinella-Jaegle S, G Rawadi, S Kawai, S Gallea, C Faucheu, P Mollat, B Courtois, B Bergand, V Ramez, et al. (2001). Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation. J Cell Sci 114: 2085-2094
46. Tang QQ and MD Lane. (2012). Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem 81:715-736
47. Roldan M, M Macias-Gonzalez, R Garcia, FJ Tinahones and M Martin. (2011). Obesity short-circuits stemness gene network in human adipose multipotent stem cells. FASEB J 25:4111-4126
48. Orford KW and DT Scadden. (2008). Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat Rev Genet 9:115-128
49. Chapouton P, P Skupien, B Hesl, M Coolen, JC Moore, R Madelaine, E Kremmer, T Faus-Kessler, P Blader, ND Lawson and L Bally-Cuif. (2010). Notch activity levels control the balance between quiescence and recruitment of adult neural stem cells. J Neurosci 30:7961-7974
50. Bjornson CRR, TH Cheung, L Liu, PV Tripathi, KM Steeper and TA Rando. (2012). Notch signaling is necessary to maintain quiescence in adult muscle stem cells. Stem Cells 30:232-242
51. Fukada S, A Uezumi, M Ikemoto, S Masuda, M Segawa, N Tanimura, H Yamamoto, Y Miyagoe-Suzuki and S Takeda. (2007). Molecular signature of quiescent satellite cells in adult skeletal muscle. Stem Cells 25:2448-2459
52. Kitamoto T and K Hanaoka. (2010). Notch3 null mutation in mice causes muscle hyperplasia by repetitive muscle regeneration. Stem Cells 28:2205-2216
53. Ladi E, JT Nichols, W Ge, A Miyamoto, C Yao, L Yang, J Boulter, YE Sun, C Kintner and G Weinmaster. (2005). The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands. J Cell Biol 170:983-992
54. Kim SH, A Sehrawat, K Sakao, ER Hahm and SV Singh. (2011). Notch activation by phenethyl isothiocyanate attenuates its inhibitory effect on prostate cancer cell migration. PLoS One 6:e26615
55. Wang T, N You, K Tao, X Wang, G Zhao, N Xia, N Li, L Tang, W Liu and K Dou. (2012). Notch is the key factor in the process of fetal liver stem/progenitor cells differ-entiation into hepatocytes. Dev Growth Differ 54:605-617
56. Gray SL, E Dalla Nora, J Grosse, M Manieri, T Stoeger, G Medina-Gomez, K Burling, S Wattler, A Russ, et al. (2006). Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator activated receptor g function (P465L PPARg) in mice. Diabetes 55:2669-2677
57. Hernández Vera R, G Vilahur, R Ferrer-Lorente, E Pena and L Badimon. (2012). Platelets derived from the bone marrow of diabetic animals show dysregulated endoplasmic reticulum stress proteins that contribute to increased thrombosis. Arterioscler Thromb Vasc Biol 32:2141-2148.